# Evaluation of Safety and Effectiveness of the BioMimics 3D Stent System

Study · id `cardio:ct-nct02400905` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02400905](<https://clinicaltrials.gov/study/NCT02400905>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT02400905

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 271 participants.

## Technical summary

Registry record NCT02400905. Allocation not applicable; no masking; primary purpose treatment. Start 2015-06-29 (actual); primary completion 2017-11-03 (actual). Results posted on 2019-01-18.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 271 participants (enrolled count; ClinicalTrials.gov record NCT02400905, source copy `cardio:ctgov-nct02400905-2021-06-04`, retrieved 2026-10-31)
- Started: 2015-06-29 (actual) (ClinicalTrials.gov record NCT02400905, source copy `cardio:ctgov-nct02400905-2021-06-04`, retrieved 2026-10-31)
- Primary completion: 2017-11-03 (actual) (ClinicalTrials.gov record NCT02400905, source copy `cardio:ctgov-nct02400905-2021-06-04`, retrieved 2026-10-31)
- Completion: 2019-12-03 (actual) (ClinicalTrials.gov record NCT02400905, source copy `cardio:ctgov-nct02400905-2021-06-04`, retrieved 2026-10-31)
- Results first posted: 2019-01-18 (ClinicalTrials.gov record NCT02400905, source copy `cardio:ctgov-nct02400905-2021-06-04`, retrieved 2026-10-31)
- Countries: United States; Germany; Japan (ClinicalTrials.gov record NCT02400905, source copy `cardio:ctgov-nct02400905-2021-06-04`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02400905-2021-06-04`, retrieved 2026-10-31)

## The registry's words

- Brief title: Evaluation of Safety and Effectiveness of the BioMimics 3D Stent System
- Acronym: MIMICS-2
- Condition: Peripheral Arterial Disease
- Intervention (Device): BioMimics 3D Vascular Stent System
- Lead sponsor: Veryan Medical Ltd.
- Lead sponsor class: INDUSTRY
- Collaborator: ClinLogix. LLC
- Collaborator class: INDUSTRY
- Collaborator: Yale Cardiovascular Research Group
- Collaborator class: OTHER
- Collaborator: Massachusetts General Hospital
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Peripheral artery disease (`cardio:peripheral-artery-disease`)
- Registry lists this organization as a collaborator: ClinLogix. LLC (`cardio:org-clinlogix-llc`)
- Registry lists this organization as a collaborator: Yale Cardiovascular Research Group (`cardio:org-yale-cardiovascular-research-group`)
- Registry lists this organization as a collaborator: Massachusetts General Hospital (`cardio:org-massachusetts-general-hospital`)

## Provenance

Content hash: 9f54217a96e7c6999b3be99635e650f179336dc79c2406e7dc47af47caa984f1
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
